Grand Pharmaceutical Group (HKSE:00512) 3-Year Revenue Growth Rate : 17.60% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Grand Pharmaceutical Group 3-Year Revenue Growth Rate?

Grand Pharmaceutical Group's Revenue per Share for the six months ended in Dec. 2023 was HK$1.30.

During the past 12 months, Grand Pharmaceutical Group's average Revenue per Share Growth Rate was 11.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 17.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Grand Pharmaceutical Group was 152.70% per year. The lowest was -47.50% per year. And the median was 13.40% per year.

Competitive Comparison of Grand Pharmaceutical Group's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grand Pharmaceutical Group's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Grand Pharmaceutical Group's 3-Year Revenue Growth Rate falls into.

Grand Pharmaceutical Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Grand Pharmaceutical Group (HKSE:00512) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Grand Pharmaceutical Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Grand Pharmaceutical Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Grand Pharmaceutical Group (HKSE:00512) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (HKSE:00512) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

MX6A:Germany

Address

99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG

Website

http://www.chinagrandpharm.com

Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.

Grand Pharmaceutical Group (HKSE:00512) Headlines

No Headlines